Low prevalence of hereditary hemochromatosis in multiethnic populations in Northern Norway

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 3, 2011, Pages 350-357

  Broderstad, Ann R ^a,b   Smith Sivertsen, Tone ^c   Dahl, Inger Marie ^b   Ingebretsen, Ole Christian ^b   Lund, Eiliv ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Ferritin; hereditary hemochromatosis; Kven; Sami; transferrin saturation

Indexed keywords

FERRITIN; TRANSFERRIN;

ADULT; ARTICLE; BLOOD SAMPLING; ETHNIC DIFFERENCE; FEMALE; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NORWAY; PREVALENCE; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; FEMALE; FERRITINS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; NORWAY; PHENOTYPE; PREVALENCE; TRANSFERRIN;

EID: 79751469579     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.525713     Document Type: Article

References (26)

1. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K, Fjosne U, et al. Screening for hemochro-matosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001; 36:1108-15. (Pubitemid 32801699)
2. Bell H, Thordal C, Raknerud N, Hansen T, Bosnes V, Halvorsen R, et al. Prevalence of hemochromatosis among first-time and repeat blood donors in Norway. J Hepatol 1997;26:272-9. (Pubitemid 27077424)
3. Distante S, Berg JP, Lande K, Haug E, Bell H. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol 1999;34:529-34. (Pubitemid 29307826)
4. Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood 2004;103:2914-19. (Pubitemid 38451659)
5. Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, et al. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening. 2007;11: 269-75.
6. Olynyk JK, Hagan SE, Cullen DJ, Beilby J, Whittall DE. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study Mayo Clin Proc 2004; 79:309-13. (Pubitemid 38269232)
7. Waalen J, Nordestgaard BG, Beutler E. The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol 2005;18:203-20. (Pubitemid 40298365)
8. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000; 133:329-337.
9. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-78. (Pubitemid 40570925)
10. Beckman LE, Saha N, Spitsyn V, Van LG, Beckman L. Ethnic differences in the HFE codon 282 (Cys/Tyr) poly-morphism. Hum Hered 1997;47:263-7. (Pubitemid 27434541)
11. Smith-Sivertsen T, Lund E, Thomassen Y, Norseth T. Human nickel exposure in an area polluted by nickel refining: the Sor-Varanger study. Arch Environ Health 1997;52: 464-71. (Pubitemid 28168594)
12. Jorde R, Haug E, Figenschau Y, Hansen JB. Serum levels of vitamin D and haemostatic factors in healthy subjects: the Tromso study. Acta Haematol 2007;117:91-7.
13. Mangasser-Stephan K, Tag C, Reiser A, Gressner AM. Rapid genotyping of hemochromatosis gene mutations on the LightCycler with fluorescent hybridization probes. Clin Chem 1999;45:1875-8. (Pubitemid 29477354)
14. Bhopal R Concepts of epidemiology an integrated introduc-tion to the ideas, theories, principles and methods of epide-miology. New York; 2002.
15. Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis 2003;31:262-7.
16. McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N, et al. Hemochromatosis and Iron Overload Screen-ing (HEIRS) study design for an evaluation of 100,000 pri-mary care-based adults. Am J Med Sci 2003;325:53-62. (Pubitemid 36236661)
17. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test 2000;4:183-98. (Pubitemid 30618706)
18. Pedersen P, Melsen Vedel G, Milman N. Frequencies of the haemochromatosis gene (HFE) variants C282Y, H63D and S65C in 6,020 ethnic Danish men. Ann Hematol 2008;87: 735-40.
19. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G-> A (C282Y) HFE hereditary haemo-chromatosis mutation in the USA. Lancet 2002;359: 211-18. (Pubitemid 34113819)
20. Waalen J, Felitti VJ, Gelbart T, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effec-tive approach. Blood 2008;111:3373-6.
21. Broderstad AR, Melhus M, Lund E. Iron status in a mul-tiethnic population (age 36-80 yr) in northern Norway: the SAMINOR study. Eur J Haematol 2007;79:447-54. (Pubitemid 47556486)
22. Milman N, Byg KE, Mulvad G, Pedersen HS, Bjerregaard P. Iron status markers in 224 indigenous Green-landers: influence of age, residence and traditional foods. Eur J Haematol 2001;66:115-25. (Pubitemid 32154105)
23. Knutsen H, Hammerstrøm J Handlingsplan for hemokro-matose. Norsk Selskap for Hematologi 2003. http://www. legeforeningen.no/asset/47362/1/47362- 1.doc.
24. Drammeh BS, Schleicher RL, Pfeiffer CM, Jain RB, Zhang M, Nguyen PH. Effects of delayed sample processing and freezing on serum concentrations of selected nutritional indicators. Clin Chem 2008;54:1883-91.
25. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Penetrance of hemochromatosis. Blood Cells Mol Dis 2002;29:418-32.
26. Saven A, Beutler E. Iron overload after prolonged intramus-cular iron therapy. N Engl J Med 1989;321:331-2.